Minorities and HIV Vaccine Trials

Paper Summary:

In recent years, HIV has begun to move away from being an automatic death sentence and toward the status of being a chronic, but manageable illness. This paper presents an examination of HIV vaccine clinical trials and examines whether or not minorities are comfortable participating in them. The writer examines the historic Tuskegee syphilis trial and applies some of the problems there to the current hesitancy by minorities to participate in HIV vaccines clinical trials. The paper is based on a literature review.

From the Paper:

"The medical community has a documented lack of minority volunteers willing to participate in clinical trials for HIV medications and other treatments. There are several factors that contribute to this trend including a basic mistrust that the minority will be given a fair amount of the treatment in question, as well as historic problems with medical trials and minorities in the past.
(Timeline http://www.cdc.gov/nchstp/od/tuskegee/time.htm)
The need to recruit minority participants for clinical trials is obvious. Minority people get ill and they get disorders. They are part of the population that the medical community is attempting to assist and their participation in clinical trials can help that process move more quickly and efficiently."

More papers on Minorities and HIV Vaccine Trials:

• Term Paper # 9995 : "The Search for an HIV Vaccine"
• Essay # 36055 : "AIDS and HIV"
• Analytical Essay # 123827 : "Vaccines and HIV"

APA Citation:

MLA Citation: